Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial. Issue 2 (21st February 2019)

• Record Type: Journal Article
• Authors: Perger, Elisa; Lyons, Owen D.; Inami, Toru; Smith, Stephanie; Floras, John S.; Logan, Alexander G.; Bradley, T. Douglas
• Other Names: author non-byline.; Bradley T.D. author non-byline.; Floras J.S. author non-byline.; Logan A.G. author non-byline.; author non-byline.; Bradley T.D. author non-byline.; Floras J.S. author non-byline.; Logan A.G. author non-byline.; Delgado D.H. author non-byline.; Kimoff R.J. author non-byline.; Dunlap M. author non-byline.; Lorenzi-Filho G. author non-byline.; Redolfi S. author non-byline.; Parati G. author non-byline.; Arzt M. author non-byline.; Durán Cantolla J. author non-byline.; Kasai T. author non-byline.; author non-byline.; Smith E.R. author non-byline.; Johnstone D. author non-byline.; Collins R. author non-byline.; author non-byline.; Joyner C. author non-byline.; Floras J.S. author non-byline.; Mak S. author non-byline.; Delgado D.H. author non-byline.; Oechslin E. author non-byline.; de Campos C. author non-byline.; Cavalho G. author non-byline.; Perger E. author non-byline.; Inami T. author non-byline.; Anderson K. author non-byline.; author non-byline.; Bradley T.D. author non-byline.; Floras J.S. author non-byline.; Logan A.G. author non-byline.; Ryan C.M. author non-byline.; Delgado D.H. author non-byline.; Mak S. author non-byline.; Tomlinson G. author non-byline.; Leung R.S. author non-byline.; Morrison D. author non-byline.; Fitzpatrick M. author non-byline.; Mayer P. author non-byline.; Kimoff R.J. author non-byline.; Mielniczuk L. author non-byline.; Beanlands R. author non-byline.; Series F. author non-byline.; Fleetham J.A. author non-byline.; Ayas N. author non-byline.; Demers C. author non-byline.; Powles A.C.P. author non-byline.; Rinne C. author non-byline.; Giannouli E. author non-byline.; Povitz M. author non-byline.; Dal Nogare A. author non-byline.; Dunlap M. author non-byline.; Shanmugasundaram M. author non-byline.; Lorenzi-Filho G. author non-byline.; Drager L. author non-byline.; Bittencourt L.R. author non-byline.; Amodeo C. author non-byline.; Bertolami A. author non-byline.; Pedrosa R. P. author non-byline.; Pérez M. Mayos author non-byline.; Canadell P. Lloberes author non-byline.; Jimenez J.F. Masa author non-byline.; Barbé F. author non-byline.; González Mangado N.P. author non-byline.; Campo F. Del author non-byline.; Cantolla J. Durán author non-byline.; Marin Trigo J.M. author non-byline.; González Martinez M. author non-byline.; Arzt M. author non-byline.; Randerath W. author non-byline.; La Rovere M.T. author non-byline.; Parati G. author non-byline.; Tantucci C. author non-byline.; Braghiroli A. author non-byline.; Raccagni D. author non-byline.; Redolfi S. author non-byline.; de Roquefeuil F. author non-byline.; Goutorbe F. author non-byline.; Escourrou P. author non-byline.; d'Ortho M-P. author non-byline.; Puel V. author non-byline.; Tamisier R. author non-byline.; Williams A. author non-byline.; Kasai T. author non-byline.; Takata Y. author non-byline.; Chin K. author non-byline.; Murase K. author non-byline.; Narui K. author non-byline.; Tomita Y. author non-byline.;
• Is Part Of: European respiratory journal. Volume 53:Issue 2(2019)
• Publication Date: 2019-02-21
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01626-2018
• Languages: English
• ISSNs: 0903-1936

Abstract

Despite its effectiveness in suppressing sleep disordered breathing (SDB), positive airway pressure therapy (PAP) is not always well tolerated by patients and long-term adherence can be problematic. Recently, two multicentre, randomised clinical trials (RCTs) tested the effects of PAP for patients with cardiovascular disease and co-existing SDB on morbidity and mortality with negative outcomes [1, 2]. Relatively poor adherence to PAP therapy (mean 3.7 and 3.3 h·day −1, respectively) in these two trials might have contributed to their poor results. Indeed, higher PAP use per day is associated with better clinical outcomes than lower use [3]. Adherence to sleep apnoea treatment is essential to evaluate trials involving cardiovascular end-points. In patients with heart failure and obstructive or central sleep apnoea in the ADVENT-HF trial, adherence to adaptive servoventilation was very good. http://ow.ly/5sNz30mDj2W